|
审核状态: Project audit state: |
通过审核 Successful |
|
注册号: Registration number: |
ChiCTR1800016784 |
|
最近更新日期: Date of Last Refreshed on: |
2018-06-24 06:42:28 |
|
注册时间: Date of Registration: |
2018-06-24 00:00:00 |
|
注册号状态: |
预注册 |
|
Registration Status: |
Prospective registration |
|
注册题目: |
多中心盆底重建手术中补片(合成网片)/自身组织的并发症研究(二) |
|
Public title: |
A multicenter study for follow-up of complications for women having pelvic reconstruction surgery with mesh/native tissue (Part II) |
|
注册题目简写: |
|
|
English Acronym: |
|
|
研究课题的正式科学名称: |
多中心盆底重建手术中补片(合成网片)/自身组织的并发症研究 |
|
Scientific title: |
A multicenter study for follow-up of complications for women having pelvic reconstruction surgery with mesh/native tissue. |
|
研究课题代号(代码): Study subject ID: |
|
|
在二级注册机构或其它机构的注册号: The registration number of the Partner Registry or other register: |
|
申请注册联系人: |
梁硕 |
研究负责人: |
朱兰 |
|
Applicant: |
Shuo Liang |
Study leader: |
Lan Zhu |
|
申请注册联系人电话: Applicant telephone: |
+86 13718879529 |
研究负责人电话:
Study leader's |
+86 13911714696 |
|
申请注册联系人传真 : Applicant Fax: |
研究负责人传真: Study leader's fax: |
||
|
申请注册联系人电子邮件: Applicant E-mail: |
leahleung@foxmail.com |
研究负责人电子邮件: Study leader's E-mail: |
zhu_julie@vip.sina.com |
|
申请单位网址(自愿提供): Applicant website(voluntary supply): |
研究负责人网址(自愿提供): Study leader's website(voluntary supply): |
||
|
申请注册联系人通讯地址: |
北京市东城区帅府园1号北京协和医院妇产科 |
研究负责人通讯地址: |
北京市东城区帅府园1号北京协和医院妇产科 |
|
Applicant address: |
1 Shuaifuyuan, Dongcheng District, Beijing, China |
Study leader's address: |
1 Shuaifuyuan, Dongcheng District, Beijing, China |
|
申请注册联系人邮政编码: Applicant postcode: |
100730 |
研究负责人邮政编码: Study leader's postcode: |
100730 |
|
申请人所在单位: |
中国医学科学院北京协和医院 |
||
|
Applicant's institution: |
Peking Union Medical College Hospital, Chinese Academy of Medicine Sciences |
||
|
研究负责人所在单位: |
中国医学科学院北京协和医院 |
||
|
Affiliation of the Leader: |
Peking Union Medical College Hospital, Chinese Academy of Medicine Sciences |
||
|
是否获伦理委员会批准: |
是 |
||
|
Approved by ethic committee: |
Yes |
||
|
伦理委员会批件文号: Approved No. of ethic committee: |
JS-1566 |
伦理委员会批件附件: Approved file of Ethical Committee: |
查看附件View |
|
批准本研究的伦理委员会名称: |
中国医学科学院北京协和医院伦理审查委员会 |
||
|
Name of the ethic committee: |
the PUMCH ethcis committee |
||
|
伦理委员会批准日期: Date of approved by ethic committee: |
2018-04-24 00:00:00 | ||
|
伦理委员会联系人: |
徐辉 |
||
|
Contact Name of the ethic committee: |
Hui Xu |
||
|
伦理委员会联系地址: |
北京市东城区帅府园一号中国医学科学院北京协和医院伦理审查委员会 |
||
|
Contact Address of the ethic committee: |
the PUMCH ethics committee, 1 Shuaifuyuan, Dongcheng District, Beijing, China |
||
|
伦理委员会联系人电话: Contact phone of the ethic committee: |
伦理委员会联系人邮箱: Contact email of the ethic committee: |
||
|
研究实施负责(组长)单位: |
中国医学科学院北京协和医院 |
||||||||||||||||||||||
|
Primary sponsor: |
Peking Union Medical College Hospital, Chinese Academy of Medicine Sciences |
||||||||||||||||||||||
|
研究实施负责(组长)单位地址: |
北京市东城区帅府园1号北京协和医院 |
||||||||||||||||||||||
|
Primary sponsor's address: |
1 Shuaifuyuan, Dongcheng District, Beijing, China |
||||||||||||||||||||||
|
试验主办单位(项目批准或申办者): Secondary sponsor: |
|
||||||||||||||||||||||
|
经费或物资来源: |
中国医学科学院医学与健康科技创新工程(重大协同创新项目) |
||||||||||||||||||||||
|
Source(s) of funding: |
Medical and health science and technological innovation project of Chinese Academy of Medicine Sciences (Major Collaborative Innovation Projects) |
||||||||||||||||||||||
|
研究疾病: |
女性盆底功能障碍性疾病 |
||||||||||||||||||||||
|
Target disease: |
Female pelvic floor dysfunction |
||||||||||||||||||||||
|
研究疾病代码: |
|
||||||||||||||||||||||
|
Target disease code: |
|
||||||||||||||||||||||
|
研究类型: |
治疗研究 |
||||||||||||||||||||||
|
Study type: |
Treatment study |
||||||||||||||||||||||
|
研究所处阶段: |
其它 | ||||||||||||||||||||||
|
Study phase: |
N/A |
||||||||||||||||||||||
|
研究设计: |
队列研究 |
||||||||||||||||||||||
|
Study design: |
Cohort study |
||||||||||||||||||||||
|
研究目的: |
了解不同盆底重建手术术后并发症的发生及分布情况 |
||||||||||||||||||||||
|
Objectives of Study: |
To study the incidence and distribution of complications after different pelvic reconstruction surgeries (mesh/native tissue) in multi-centers. |
||||||||||||||||||||||
|
药物成份或治疗方案详述: |
收集2018年6月至2023年6月在全国27家参加研究的医院诊治的新发的网片、吊带、自身组织并发症患者资料,包括在本院手术治疗以及外院(但除外其它26家医院)手术治疗的患者,根据IUGA/ICS制定的并发症分类系统(CTS编码系统)分别予以登记。 |
||||||||||||||||||||||
|
Description for medicine or protocol of treatment in detail: |
Our study aims to investigate and report the status of complications after different pelvic floor reconstructive surgeries using mesh, tape and native tissue between June 2018 and June 2023 from 27 tertiary hospitals. The data of postoperative complications were classified and recorded according to the International Urogynecological Association-International Continence Society(IUGA-ICS)Complication Classification Coding(Category-Time-Site coding system). |
||||||||||||||||||||||
|
纳入标准: |
2018年6月至2023年6月在全国27家参加研究的医院诊治“新发现” 的盆底重建手术术后的并发症患者,包括在本院手术治疗以及外院(但除外26家医院)手术治疗的患者。 |
||||||||||||||||||||||
|
Inclusion criteria |
Patients are inferred to 27 tertiary hospitals with the complaint of de novo complications after pelvic reconstructive surgeries using mesh, tape and native tissue between June 2018 and June 2023. The subjects include patients who accept treatment not only at our participating hospitals but also from other hospital. |
||||||||||||||||||||||
|
排除标准: |
盆底重建手术术后出现并发症的同一名患者,因“相同并发症”在27家参加研究医院已就诊诊治的,再次就诊于另外26家医院,不做重复例次计算。 |
||||||||||||||||||||||
|
Exclusion criteria: |
If the same patient who developed complications after pelvic floor reconstructive surgeries has been diagnosed and reported in 27 participating hospitals, and again treated for "the same code complication in other 26 hospitals, she will be ruled out. |
||||||||||||||||||||||
|
研究实施时间: Study execute time: |
从 From 2017-11-01 00:00:00至 To 2023-06-30 00:00:00 |
征募观察对象时间: Recruiting time: |
从 From 2018-06-30 00:00:00 至 To 2023-06-30 00:00:00 |
|
干预措施: Interventions: |
|
|
研究实施地点: Countries of recruitment and research settings: |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
测量指标: Outcomes: |
|
|
采集人体标本:
Collecting sample(s)
|
|
|
征募研究对象情况: Recruiting status: |
正在进行 Recruiting |
年龄范围: Participant age: |
|
||||||
|
性别: |
女性 |
Gender: |
Female |
||||||
|
随机方法(请说明由何人用什么方法产生随机序列): |
N/A |
||||||||
|
Randomization Procedure (please state who generates the random number sequence and by what method): |
N/A |
||||||||
|
是否公开试验完成后的统计结果: Calculated Results after the Study Completed public access: |
公开/Public |
|
盲法: |
|
|
Blinding: |
|
|
试验完成后的统计结果(上传文件): |
|
|
Calculated Results after
|
|
|
是否共享原始数据: IPD sharing |
是Yes |
|
共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址): |
2023年12月,中国临床试验注册中心,www.chictr.org.cn |
|
The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url): |
By December,2023;http://www.chictr.org.cn |
|
数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC: |
数据采集采用EDC方式 |
|
Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture: |
Electronic Data Capture |
|
数据与安全监察委员会: Data and Safety Monitoring Committee: |
有/Yes |